Durability of glycemic control with insulin lispro mix 75/25 versus insulin glargine for older patients with type 2 diabetes.
Journal Information
Full Title: Aging Clin Exp Res
Abbreviation: Aging Clin Exp Res
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict of interest None."
Funding Disclosure
Evidence found in paper:
"This study was funded by Eli Lilly and Company. H.H.J. and D.S.H are employees and shareholders of Eli Lilly and Company. A.L.P. has been reimbursed by the following companies for speaking and/or ad hoc consulting: Amylin, Eli Lilly and Company, Novo Nordisk and Sanofi. L.J. has no competing interests to declare. The authors wish to acknowledge Michelle Carey of inVentiv Health Clinical, for providing writing assistance."
Protocol Registration
Evidence found in paper:
"Clinical trial registration number: NCT00279201."
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025